These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20082475)

  • 41. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparan sulfate proteoglycans in glomerular inflammation.
    Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
    Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
    Tumova S; Hatch BA; Law DJ; Bame KJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery and development of small-molecule heparanase inhibitors.
    Zhang Y; Cui L
    Bioorg Med Chem; 2023 Jul; 90():117335. PubMed ID: 37257254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.
    Yang JM; Wang HJ; Du L; Han XM; Ye ZY; Fang Y; Tao HQ; Zhao ZS; Zhou YL
    Cancer Immunol Immunother; 2009 Sep; 58(9):1387-96. PubMed ID: 19169879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of heparanase in tumor progression: Molecular aspects and therapeutic options.
    Masola V; Zaza G; Gambaro G; Franchi M; Onisto M
    Semin Cancer Biol; 2020 May; 62():86-98. PubMed ID: 31348993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
    Pinhal MAS; Melo CM; Nader HB
    Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
    Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
    J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of heparanase in migration of microglial cells.
    Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
    Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumorigenic and adhesive properties of heparanase.
    Levy-Adam F; Ilan N; Vlodavsky I
    Semin Cancer Biol; 2010 Jun; 20(3):153-60. PubMed ID: 20619346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.
    Rabelink TJ; van den Berg BM; Garsen M; Wang G; Elkin M; van der Vlag J
    Nat Rev Nephrol; 2017 Apr; 13(4):201-212. PubMed ID: 28163306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The function of heparanase in diabetes and its complications.
    Wang F; Wan A; Rodrigues B
    Can J Diabetes; 2013 Oct; 37(5):332-8. PubMed ID: 24500561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells.
    de Mestre AM; Rao S; Hornby JR; Soe-Htwe T; Khachigian LM; Hulett MD
    J Biol Chem; 2005 Oct; 280(42):35136-47. PubMed ID: 16093249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.
    Tátrai P; Egedi K; Somorácz A; van Kuppevelt TH; Ten Dam G; Lyon M; Deakin JA; Kiss A; Schaff Z; Kovalszky I
    J Histochem Cytochem; 2010 May; 58(5):429-41. PubMed ID: 20124094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Processing and activation of latent heparanase occurs in lysosomes.
    Zetser A; Levy-Adam F; Kaplan V; Gingis-Velitski S; Bashenko Y; Schubert S; Flugelman MY; Vlodavsky I; Ilan N
    J Cell Sci; 2004 May; 117(Pt 11):2249-58. PubMed ID: 15126626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.